Novartis Wins Punitive Damages Ruling In Aredia Suits

By Allison Grande (July 19, 2010, 5:37 PM EDT) -- Novartis Pharmaceuticals Corp. has won its bid to apply New Jersey law to the plaintiffs' claims for punitive damages in two product liability suits accusing the drugmaker of failing to adequately warn that its bone cancer drugs Aredia and Zometa could cause jawbone deterioration.

Judge Arthur D. Spatt of the U.S. District Court for the Eastern District of New York on Friday resolved the parties' dispute over whether New York or New Jersey law on punitive damages should be applied in these suits, ruling that the plaintiffs had failed to adequately rebut Novartis' argument that the conduct at issue took place...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!